13 research outputs found

    Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia

    Get PDF
    <div><p>The survival and proliferation of CLL cells depends on microenvironmental contacts in lymphoid organs. CD38 is a cell surface receptor that plays an important role in survival and proliferation signaling in CLL. In this study we demonstrate SYK's direct involvement in the CD38 signaling pathway in primary CLL samples. CD38 stimulation of CLL cells revealed SYK activation. SYK downstream target AKT was subsequently induced and MCL-1 expression was increased. Concomitant inhibition of SYK by the SYK inhibitor R406 resulted in reduced activation of AKT and prevented upregulation of MCL-1. Moreover, short-term CD38 stimulation enhanced BCR-signaling, as indicated by increased ERK phosphorylation. CXCL12-dependent migration was increased after CD38 stimulation. Treating CLL cells with R406 inhibited CD38-mediated migration. In addition, we observed marked downregulation of CD38 expression for CLL cells treated with R406 compared to vehicle control. Finally, we observed a clear correlation between CD38 expression on CLL cells and SYK-inhibitor efficacy. In conclusion, our study provides deeper mechanistic insight into the effect of SYK inhibition in CLL.</p></div

    SYK mediates CD38 induced AKT activation and MCL-1 expression.

    No full text
    <p>A) Western blot analysis of pAKT (Ser473) induction after incubation of CLL cells with IB4 for 15 min with or without concomitant R406 treatment (n = 8, p<0.05). B) Western Blot analysis of MCL-1 expression after 24 hs of CD31 ligation with or without concomitant SYK inhibition (n = 12, p<0.05 and p<0.01). Error bars indicate SEM.</p

    SYK is rapidly induced upon CD38 stimulation.

    No full text
    <p>CD38 stimulation of primary CLL cells was performed using recombinant human CD31. A) Initial activation of SYK by phosphorylation of tyrosine residue 352 was detected after exposure of CLL cells to CD31 for 15 sec (n = 6, p<0.01) (left). Middle: Before and After Plot of 6 CLL patients. Right: A representative example of n = 6 independent experiments is shown. B) Trans-autophosphorylation of SYK upon CD38 activation was analyzed by western blot using a SYK Y(525/526) specific antibody. Left: densitometric analysis of pSYK western blots after CD31 ligation for 1 minute, 10, or 15 minutes (n = 8, p<0.01). Error bars indicate SEM. Right: A representative example of n = 8 independent experiments is shown.</p

    CD38 surface expression is dependent on SYK.

    No full text
    <p>Surface expression on CLL cells was analyzed by flow cytometry. A) Analysis of CD38 expression on CLL cells after 24 hs SYK inhibitor treatment (4ÎŒM R406 and 2 ÎŒM P505-15, respectively) (n = 8, p<0.001). B) Analysis of CD5 surface expression on SYK inhibitor treated CLL cells (n = 8, p = 0.31 and p = 0.42). C) Analysis of CD38 expression after stimulation with CD40L for 24 hs (n = 9, p<0.01 and p<0.05). Error bars indicate SEM.</p

    The effect of SYK inhibition on cell viability positively correlates with CD38 expression.

    No full text
    <p>A) Primary CLL cells were tested for CD38 surface expression by flow cytometry. Cells were subsequently treated with 4 ÎŒM R406 for 24 hs. Induction of apoptosis was analyzed by Annexin V/PI staining. Correlating the rate of apoptosis with CD38 surface expression was analyzed by Spearman rank test (n = 17, p<0.01, Spearman: r = 0.73). B) Primary CLL cells were labeled with APC-labelled anti-CD38 antibody and sorted into CLL cells with CD38<sup>high</sup> and CD38<sup>low</sup> expression. Cells were subsequently treated with 4 ÎŒM R406 for 24 hs. Apoptosis induction was analyzed by flow cytometry using Annexin V/PI staining (n = 10, p<0.05). Error bars indicate SEM.</p
    corecore